No products
View larger
More info
The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards published within provide a scientific basis for quality control during the entire life cycle of a product.
These standards are legally binding - as laid down in the Council of Europe's Convention on the elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all signatory member states of the Convention.
Key features:
-
Approximately 30% of the content is new or revised compared to Edition 9.0 with 114 new and 683 revised texts.
-
The Pharmacopoeia you need to comply with in order to market your products in 38 European countries and beyond.
-
Delivers crucial information earlier than any other Pharmacopoeia.
-
Contains 2,420 monographs, 374 general texts (including general monographs and methods of analysis) and around 2,780 descriptions of reagents.
NEW electronic version providing:
-
The 2020 subscription will provide access until 31 December 2020 to the content of 10.0 and the first 2 cumulative updates, 10.1 and 10.2, as well as to the Ph. Eur. online archives and direct access to complementary information (Knowledge Database).
-
A single licence provides named user access to one named person along with the ability to download an application for online and offline use to 1 computer* and 1 USB stick.
-
Customers who purchase multiple licences will be able to assign a licence manager to manage the users of the licences. This licence manager who registers the EPID code must also be a user.
-
Completely cumulative versions, bilingual (English and French), with new features and direct access to complementary information (Knowledge Database).
-
Contains direct links to texts, improved search query management and improved visibility of changes (for revised and corrected texts)